The association between mortality due to COVID-19 and coagulative parameters: a systematic review and meta-analysis study
- PMID: 39623325
- PMCID: PMC11610108
- DOI: 10.1186/s12879-024-10229-y
The association between mortality due to COVID-19 and coagulative parameters: a systematic review and meta-analysis study
Abstract
Aims and objectives: This systematic review and meta-analysis study evaluated the association between mortality due to COVID-19 and coagulative factors.
Methods: A systematic search was conducted on electronic databases including PubMed, Scopus, and the Web of Science from the beginning of the pandemic until October 2024 to identify relevant studies on COVID-19 patients and their laboratory findings related to coagulation markers and mortality outcome. Eligibility criteria were defined based on the PICO framework, and data extraction was performed by two authors independently using a standardized sheet. Statistical analysis was accomplished using the random effects model, and heterogeneity among studies was assessed using the I2 test. R and RStudio were used for statistical analysis and visualization.
Results: Our systematic literature search yielded 6969 studies, with 48 studies meeting the inclusion criteria for our meta-analysis. The mean platelet count was significantly lower in deceased COVID-19 patients compared to survivors (20.58), while activated partial thromboplastin time (aPTT) and fibrinogen levels did not show significant differences. The pooled mean difference of D-Dimer, International Normalized Ratio (INR), and prothrombin time (PT) were significantly lower in survived patients (-2.45, -0.10, and -0.84, respectively). These findings suggest that platelet count, D-Dimer, INR, and PT may serve as potential indicators of mortality in COVID-19 patients.
Conclusion: The results of our systematic review and meta-analysis revealed a significant reduction in the pooled platelet count among deceased individuals when compared to survivors. However, no significant distinctions were observed in the pooled mean activated aPTT and fibrinogen levels between the deceased and survivor groups. On the other hand, there were noticeable variations in the pooled estimated mean of INR, PT, and D-Dimer levels, with significantly higher values in the deceased group compared to those who survived.
Keywords: COVID-19; Coagulopathy; D-dimers; Fibrinogen; Meta-analysis; Mortality; Prothrombin time.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The protocol for this systematic review was approved by the ethics committee at IKHC ethics committee (Ethics code: IR.TUMS.IKHC.REC.1399.102). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures







Similar articles
-
INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression.Adv Med Sci. 2021 Sep;66(2):372-380. doi: 10.1016/j.advms.2021.07.009. Epub 2021 Jul 21. Adv Med Sci. 2021. PMID: 34315012 Free PMC article.
-
Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19.Int J Infect Dis. 2020 Nov;100:441-448. doi: 10.1016/j.ijid.2020.09.021. Epub 2020 Sep 15. Int J Infect Dis. 2020. PMID: 32947052 Free PMC article.
-
[Analysis of the factors associated with abnormal coagulation and prognosis in patients with non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25404269 Free PMC article. Chinese.
-
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12466-12479. doi: 10.26355/eurrev_202012_24043. Eur Rev Med Pharmacol Sci. 2020. PMID: 33336766
-
Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.J Clin Lab Anal. 2010;24(3):163-6. doi: 10.1002/jcla.20383. J Clin Lab Anal. 2010. PMID: 20486197 Free PMC article.
Cited by
-
Complex Pattern of Platelet Activation/Reactivity After SARS-CoV-2 Infection.Int J Mol Sci. 2024 Dec 24;26(1):49. doi: 10.3390/ijms26010049. Int J Mol Sci. 2024. PMID: 39795908 Free PMC article. Review.
-
Optimizing Clinical Management of COVID-19: A Predictive Model for Unvaccinated Patients Admitted to ICU.Pathogens. 2025 Feb 27;14(3):230. doi: 10.3390/pathogens14030230. Pathogens. 2025. PMID: 40137715 Free PMC article.
References
-
- Wolny M, Dittrich M, Knabbe C, Birschmann I. Immature platelets in COVID-19. Platelets. 2023;34(1):2184183. - PubMed
-
- Rurua M, Ratiani L, Sanikidze T, Machvariani K, Pachkoria E, Ormocadze G, et al. Impact of the angiotensin-converting enzyme (ACE) inhibitors on the course of the septic shock developed during covid-19 and other severe respiratory infections in presence of hyperferritinemia. Georgian Med News. 2023;337:110–7. - PubMed
-
- Zhu G, Modepalli S, Anand M, Li H. Computational modeling of hypercoagulability in COVID-19. Comput Methods Biomech Biomed Engin. 2023;26(3):338–49. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical